Panacea Biotec Ltd appoints additional director

The Board of Directors of Panacea Biotec Ltd has, on the recommendation of Nomination and Remuneration Committee, appointed Mr. Narotam Kumar Juneja (DIN: 01204817) as an additional director (in the capacity of Non-Executive Non-Independent Director) on the Board of Directors of the Company with effect from April 01, 2022.

Mr. Narotam Kumar Juneja, aged about 66 years, has done Masters in Pharmacy (M. Pharm) and Post Graduate Diploma in Personnel Management & Industrial Relations. He has rich experience of over 40 years in pharmaceutical operations (including in the Company) and has executed multiple internationally approved projects worth $150M+ for reputed companies.

He has earlier been associated with the Company as Vice President Operations & Projects during 2003-2006 and again as Chief Operating Officer during 2010-2014. He has also worked at senior positions with Dawa Group Ltd., Kenya and several other companies in India including Unichem Laboratories, Ranbaxy Laboratories, Systopic India and Dabur India.

Shares of Panacea Biotec Limited was last trading in BSE at Rs. 155.65 as compared to the previous close of Rs. 148.25. The total number of shares traded during the day was 13808 in over 311 trades.

The stock hit an intraday high of Rs. 155.65 and intraday low of 149.95. The net turnover during the day was Rs. 2122187.00.

Source : Equity Bulls

Keywords

PanaceaBiotec INE922B01023 Appointment AdditionalDirector